The Annual Congress of International Drug Discovery Science & Technology (IDDST), initiated from 2003, has been successfully organized in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA) and Kyoto (Japan) and has attracted more than 10000 participants from over 50 countries and regions in the previous 17 years. IDDST continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment.
 |
Dr. Luc Van Hijfte, SVP Medicinal Chemistry, Symeres, the Netherlands |
 |
Dr. Matthias von Herrath, Professor, La Jolla Institute; Vice President, NovoNordisk, USA |
 |
Dr. Dan Some, Principal Scientist, Wyatt Technology Corporation, USA |
 |
Dr. Balazs Sarkadi, Professor, Semmelweis University, Hungary |
 |
Dr. Uwe Schoenbeck, Senior Vice President & Chief Scientific Officer, Worldwide R & D, Pfizer, USA |
 |
Dr. Zsolt Bosnyak, Chief Medical Officer, Richter Gedeon Nyrt., France |
 |
Dr. Pirouz M, Daftarian, Director of Scientific Engagement, Crown Biosciences and MBLI, USA |
 |
Dr. Volker Lang, Managing Director, AbCheck, Czech Republic |
 |
Dr. Thijs (Mattheus) Paulus van Iersel, Senior Director of Clinical Pharmacology, Scientific Affairs - Clinical Pharmacology, PRA Health Sciences, The Netherlands |
 |
Dr. Iain L. O. Buxton, Foundation Professor, University of Nevada, USA |
 |
Dr. Alexey RAK, Director of Bio Structure and Biophysics, Sanofi R&D, France |
 |
Dr. Loui Madakamutil, SVP, Head of Biology and Preclinical Development, Nektar Therapeutics, USA |
 |
Dr. Marcus Bauser, Director, Medicinal Chemistry, Bayer AG, Germany |
 |
Dr. Henk Leeuwis, Vice President, LioniX International, the Netherlands |
 |
Dr. Florian Montel, Head of opnMe.com & CNS Project Leader, BoehringerIngelheim, Germany |
 |
Dr. Juhaeri JUHAERI, Vice President and Head, Epidemiology and Benefit-Risk Evaluation, Sanofi, USA |
 |
Dr. Mehrdad Ghashghaeinia, Professor, University Medical Center Schleswig-Holstein, Germany |
 |
Dr. Erminia Massarelli, Professor, City of Hope, USA |
 |
Dr. Stefan J. Platz, Senior Vice President, AstraZeneca, UK |
 |
Dr. John J. Miles, Professor, James Cook University, Australia |
 |
Dr. Daniel Bradley, Associate Director, Biogen, USA |
 |
Dr. Immanuel Lerner, Chief Executive Officer, Pepticom LTD, Isreal |
 |
Dr. Anthony W. Coleman, Research Director, Université de Lyon, France |
 |
Dr. Mircea Ciuca, Head, Medical Clinical Drug Safety, ViforPharma, Switzerland |
 |
Dr. Lucas P.J.J. Noldus, Founder & CEO, Noldus Information Technology bv, the Netherlands |
 |
Dr. Wilbur de Kruijf, VP, MedsprayPharma, the Netherlands |
 |
Dr. Hubert Pellikaan, NextstepPharma BV, the Netherlands |
 |
Dr. Faz Chowdhury, CEO, NemauraPharma Limited, UK |
 |
Dr. Joël Richard, Head of Technical and Pharmaceutical Operations, MedinCell, France |
 |
Dr. Khursheed Anwer, Executive Vice President & Chief Science Officer, Celsion Corporation, USA |
 |
Dr. Michael Gamlen, Chief Scientific Officer, Gamlen Tableting Ltd., UK |
 |
Dr. Michael Black, Head of Sales PHARMA, BENEO-Palatinit GmbH, Germany |
 |
Dr. Masha Poyurovsky, VicePresident, Kadmon Corporation, LLC, USA |
 |
Dr. Yaakov Naparstek, Professor of Medicine, Hadassah University Hospital, Israel |
 |
Dr. Michael Reilly, Executive Director, Alliance for Safe Biologic Medicine, USA |
 |
Dr. Luana Pesco Koplowitz, Chief Medical & Scientific Officer, DUCK FLATS Pharma, USA |
 |
Dr. Tom Mander, Chief Operating Officer, Domainex Ltd, UK |
 |
Dr. Lars Neumann, Director, Proteros biostructures GmbH, Germany |
 |
Dr. Raphael Serreau, Professor, Unité INSERM “Psycomadd“ Université Paris Sud, France |
 |
Dr. Sigrid Saaler-Reinhardt, Director, Midas Pharma GmbH, Germany |
 |
Dr. Monica Berrondo, CEO, Macromoltek - Molecular simulations simplified, USA |
 |
Dr. Andrea Cusack, CBO, Leon-nanodrugs GmbH, Germany |
 |
Dr. Hiroyuki Fukase, Director, Clinical Research Center, Clinical Research Hospital Tokyo, Japan |
 |
Dr. Didier Dubreuil, Professor, University of Nantes, France |
 |
Dr. Gilles Courtemanche, Associate Director, Antimicrobials Unit, BIOASTER, France |
 |
Dr. Eduard Stefan, Head, Institute of Biochemistry, University of Innsbruck, Austria |
 |
Dr. Albin (Jim) Nelson, Senior Principal/Owner, Schwegman Lundberg Woessner P.A., USA |
 |
Dr. Isaac Bright, Chief Executive Officer, RubrYc Therapeutics, Inc, USA |
 |
Dr. Anna Birukova, Professor of Medicine, University of Maryland, USA |
 |
Dr. Konstantin Birukov, Professor of Anesthesiology, University of Maryland, USA |
 |
Dr. Ralf Glatthar, Director, Novartis Pharma AG, Switzerland |
 |
Dr. Barry Morgan, CSO, Hitgen Ltd., USA |
 |
Dr. Roberta Bursi, Vice President R&D, InSilicoTrials Technologies, Italy |
 |
Dr. Sergey Suchkov, Director of The Center for Personalized Medicine, I.M. Sechenov First Moscow State Medical University, Russia |
 |
Dr. Michael Ovadia, Professor, Tel Aviv University, Israel |
 |
Dr. Lakshminarayan R. Ranganath, Professor, University of Liverpool, UK |
 |
Dr. Karin Schutze, CSO, CellTool GmbH, Germany |
 |
Dr. Andrew Hanneman, Associate Director, Mass Spectrometry, Charles River Laboratories, USA |
 |
Dr. Steven van Helden, Chief Technology Officer, Pivot Park Screening Centre B.V., Netherlands |
 |
Dr. Elaine M. Hull, Professor, Florida State University, USA |
IDDST-2023 provides an ideal platform to showcase your novel technologies and products in the Netherlands. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at IDDST-2023
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition
Hall
  |
Exhibition Date: |
Amsterdam is the capital city and most populous municipality of the Netherlands. Its status as the capital is mandated by the Constitution of the Netherlands. Amsterdam's main attractions include its historic canals, the Rijksmuseum, the Van Gogh Museum, the Stedelijk Museum, Hermitage Amsterdam, the Anne Frank House, the Scheepvaartmuseum, the Amsterdam Museum, the Heineken Experience, the Royal Palace of Amsterdam, Natura Artis Magistra, Hortus Botanicus Amsterdam, NEMO, the red-light district and many cannabis coffee shops. They draw more than 5 million international visitors annually. The city is also well known for its nightlife and festival activity; several of its nightclubs (Melkweg, Paradiso) are among the world's most famous. It is also one of the world's most multicultural cities, with at least 177 nationalities represented.
Dr. Godefridus J Peters, Professor, Amsterdam University Medical Centers, the Netherlands
International Transmembrane Transporter Society
International Society of Digital Medicine
The Asian Society of Natural Products
UK Pharmacogenetics and Stratified Medicine Network
The Czech Pharmaceutical Society
The National Hospital Pharmacists Association of Romanian
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
© 2003-2023 All rights reserved by BITeomics |